Current challenges with adherence to pharmacotherapy in allergic rhinitis

References

• Bousquet PJ, Leynaert B, Neukirch F, et al. Geographical distribution of atopic rhinitis in the European community respiratory health survey I. Allergy. 2008;63(10):1301–1309. doi: 10.1111/j.1398-9995.2008.01824.x
   PubMed Web of Science ®Google Scholar
• Pacheco SE, Guidos-Fogelbach G, Annesi-Maesano I, et al. Climate change and global issues in allergy and immunology. J Allergy Clin Immunol. 2021;148(6):1366–1377. doi: 10.1016/j.jaci.2021.10.011
   PubMed Web of Science ®Google Scholar
• D’Amato G, Chong-Neto HJ, Monge Ortega OP, et al. The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens. Allergy. 2020;75(9):2219–2228. doi: 10.1111/all.14476
   PubMed Web of Science ®Google Scholar
• Wise SK, Damask C, Roland LT, et al. International consensus statement on allergy and rhinology: allergic rhinitis - 2023. Int Forum Allergy Rhinol. 2023;13(4):293–859. doi: 10.1002/alr.23090
   PubMed Web of Science ®Google Scholar
• Colás C, Brosa M, Antón E, et al. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN study. Allergy. 2017;72(6):959–966. doi: 10.1111/all.13099
   PubMed Web of Science ®Google Scholar
• Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of rhinitis on work productivity: a systematic review. J Allergy Clin Immunol Pract. 2018;6(4):1274–1286.e1279. doi: 10.1016/j.jaip.2017.09.002
   PubMed Web of Science ®Google Scholar
• Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147–334. doi: 10.1067/mai.2001.118891
   PubMed Web of Science ®Google Scholar
• Bousquet J, Schünemann HJ, Togias A, et al. Next-generation allergic rhinitis and its impact on asthma (ARIA) guidelines for allergic rhinitis based on grading of recommendations assessment, development and evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70–80. e73. doi: 10.1016/j.jaci.2019.06.049
   PubMed Web of Science ®Google Scholar
• Brożek JL, Bousquet J, Agache I, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi: 10.1016/j.jaci.2017.03.050
   PubMed Web of Science ®Google Scholar
• White P, Smith H, Baker N, et al. Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy. 1998;28(3):266–270. doi: 10.1046/j.1365-2222.1998.00237.x
   PubMed Web of Science ®Google Scholar
• Zheng M, Wang X, Wang M, et al. Clinical characteristics of allergic rhinitis patients in 13 metropolitan cities of China. Allergy. 2021;76(2):577–581. doi: 10.1111/all.14561
   PubMed Web of Science ®Google Scholar
• Menditto E, Costa E, Midão L, et al. Adherence to treatment in allergic rhinitis using mobile technology. The mask study. Clin Exp Allergy. 2019;49(4):442–460. doi: 10.1111/cea.13333
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi: 10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Bousquet J, Arnavielhe S, Bedbrook A, et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin Transl Allergy. 2018;8(1):45. doi: 10.1186/s13601-018-0227-6
   PubMedGoogle Scholar
• Bousquet J, Anto JM, Annesi-Maesano I, et al. POLLAR: impact of air POLLution on asthma and rhinitis; a European institute of innovation and technology health (EIT Health) project. Clin Transl Allergy. 2018;8(1):36. doi: 10.1186/s13601-018-0221-z
   PubMedGoogle Scholar
• Brozek JL, Akl EA, Alonso-Coello P, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669–677. doi: 10.1111/j.1398-9995.2009.01973.x
   PubMed Web of Science ®Google Scholar
• Brozek JL, Akl EA, Jaeschke R, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009;64(8):1109–1116. doi: 10.1111/j.1398-9995.2009.02083.x
   PubMed Web of Science ®Google Scholar
• Brozek JL, Akl EA, Compalati E, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy. 2011;66(5):588–595. doi: 10.1111/j.1398-9995.2010.02530.x
   PubMed Web of Science ®Google Scholar
• Akkoc T, Akdis M, Akdis CA. Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res. 2011;3(1):11–20. doi: 10.4168/aair.2011.3.1.11
   PubMed Web of Science ®Google Scholar
• Noon L. Prophylactic inoculation against Hay Fever. Lancet. 1911;177(4580):1572–1573. doi: 10.1016/S0140-6736(00)78276-6
   Google Scholar
• Halken S, Larenas-Linnemann D, Roberts G, et al. EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol. 2017;28(8):728–745. doi: 10.1111/pai.12807
   PubMed Web of Science ®Google Scholar
• Pfaar O, Richter H, Sager A, et al. Persistence in allergen immunotherapy: a longitudinal, prescription data-based real-world analysis. Clin Transl Allergy. 2023;13(5):e12245. doi: 10.1002/clt2.12245
   PubMed Web of Science ®Google Scholar
• Kiel MA, Röder E, Gerth van Wijk R, et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132(2):353–60. e2. doi: 10.1016/j.jaci.2013.03.013
   PubMed Web of Science ®Google Scholar
• Casale TB, Condemi J, LaForce C, et al. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA. 2001;286(23):2956–2967. doi: 10.1001/jama.286.23.2956
   PubMed Web of Science ®Google Scholar
• Chervinsky P, Casale T, Townley R, et al. Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91(2):160–167. doi: 10.1016/S1081-1206(10)62171-0
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xi L, Gao Y, et al. Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis. Clin Transl Allergy. 2022;12(1):e12094. doi: 10.1002/clt2.12094
   PubMed Web of Science ®Google Scholar
• Okubo K, Okano M, Sato N, et al. Add-on omalizumab for inadequately controlled severe pollinosis despite standard-of-care: a randomized study. J Allergy Clin Immunol Pract. 2020;8(9):3130–3140.e3132. doi: 10.1016/j.jaip.2020.04.068
   PubMed Web of Science ®Google Scholar
• Weinstein SF, Katial R, Jayawardena S, et al. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. J Allergy Clin Immunol. 2018;142(1):171–177.e171. doi: 10.1016/j.jaci.2017.11.051
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yan B, Zhu Z, et al. Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, phase 2 trial. EClinicalMedicine. 2024 Feb 6;69:102467. doi: 10.1016/j.eclinm.2024.102467
   PubMedGoogle Scholar
• Corren J, Saini SS, Gagnon R, et al. Short-term subcutaneous allergy immunotherapy and dupilumab are well tolerated in allergic rhinitis: a randomized trial. J Asthma Allergy. 2021;14:1045–1063. doi: 10.2147/JAA.S318892
   PubMed Web of Science ®Google Scholar
• Casale TB, Busse WW, Kline JN, et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol. 2006;117(1):134–140. doi: 10.1016/j.jaci.2005.09.036
   PubMed Web of Science ®Google Scholar